Business Wire

Future Toyota Cars to be Powerd by RoboSense LiDAR for Safer Self-Driving

7.2.2023 16:06:00 EET | Business Wire | Press release

Share

RoboSense, a world-leading provider of Smart LiDAR Sensor Systems, officially announced its partnership with Toyota, the world's best-selling carmaker, on large-scale production with nominated orders for multiple models. With its advanced technology and product advantages in the global LiDAR field, RoboSense has been officially integrated into Toyota's supply chain system.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230207005749/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

RoboSense has been officially integrated into Toyota's supply chain system

Toyota has been No.1 in global sales for three consecutive years since 2020. In 2022, Toyota sold 10.5 million vehicles, winning the "Best-Selling Automaker" crown. Since the start of the 21st century, Toyota has fully carried out localized production and sales in China and established joint ventures with FAW, GAC, BYD and other domestic auto brands. As a model world-famous joint-venture car brand, a number of featured products of FAW Toyota post strong sales globally, serving as stable support for Toyota to top the global sales ranking. RoboSense and Toyota will collaborate in-depth on a number of top-selling FAW Toyota models.

By equipping them with the RS-LiDAR-M series LiDAR ("M-series" for short), RoboSense will empower Toyota models with accurate perception capabilities, guard the driving safety of Toyota's intelligent models, and promote the series production and large-scale application of LiDAR in the automotive industry. The M-series is a featured automotive-grade, revolutionary product from RoboSense for vehicle series production. It is the only second-generation smart solid-state LiDAR in the world to achieve the automotive-grade series production. It adopts a revolutionary chip-based 2D scanning solution, which boasts supreme performance and reliability. At present, the M-series has obtained nominated orders for more than 50 models from nearly 20 car companies, including Toyota, with an expected order volume of more than 10 million units.

Toyota has nearly a century of history developing durable, stable and reliable vehicles, which made it the "global top seller". RoboSense leverages its professional CNAS accredited lab and the largest production and intelligent manufacturing system in the industry to satisfy Toyota's high-quality product and large-scale production requirements.

Prior to this, RoboSense had reached partnership with BYD, a world-leading pioneer in new energy vehicles, on various models. This in-depth partnership between RoboSense and Toyota means that RoboSense has become a part of the supply chain system of both best-selling car brands worldwide at the same time, making it a leader in the global LiDAR market.

About RoboSense

RoboSense (Suteng Innovation Technology Co., Ltd.) is a world-leading provider of Smart LiDAR Sensor Systems. With a complete portfolio of LiDAR sensors, AI perception and IC chipsets, RoboSense transforms conventional 3D LiDAR sensors with comprehensive data analysis and interpretation systems. Its mission is to innovate outstanding hardware and AI capabilities to create smart solutions that enable robots, including autonomous vehicles, to have perception capabilities superior to humans.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press
Grace Ye
media@robosense.cn

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release

PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.

Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release

Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor

Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release

Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we

Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release

Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release

Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye